APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Intravenous Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NAD+ Intravenous Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025197 pages

Choose your research edition.

Industry ResearchNAD+ Intravenous Therapy Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Intravenous Therapy Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal NAD+ Intravenous Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Intravenous Therapy Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Intravenous Therapy Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global NAD+ Intravenous Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NAD+ Intravenous Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NAD+ Intravenous Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NAD+ Intravenous Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NAD+ Intravenous Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NAD+ Intravenous Therapy include Azivmedics, BioReset Medical, Conciergemdla, Effect Doctors, Hydrate IV Bar, IV Boost UK, LIVV Natural, Mobileivmedics and Nadclinic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NAD+ Intravenous Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NAD+ Intravenous Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NAD+ Intravenous Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NAD+ Intravenous Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

NAD+ Intravenous Therapy Segment by Company

Azivmedics

BioReset Medical

Conciergemdla

Effect Doctors

Hydrate IV Bar

IV Boost UK

LIVV Natural

Mobileivmedics

Nadclinic

Premiumhealth

Reset IV

Rocky Mountain Ivmedics

Seaside Skin Care

The Wellness Lab

Thedripclub

Toronto Functional Medicine Centre

NAD+ Intravenous Therapy Segment by Type

NAD+ Mixed Vitamin Injections

Pure NAD+ Injection

NAD+ Intravenous Therapy Segment by Application

Clinic

Hospital

Residential

NAD+ Intravenous Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Intravenous Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Intravenous Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Intravenous Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NAD+ Intravenous Therapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NAD+ Intravenous Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NAD+ Intravenous Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NAD+ Intravenous Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NAD+ Intravenous Therapy Industry Trends Table 2. NAD+ Intravenous Therapy Industry Drivers Table 3. NAD+ Intravenous Therapy Industry Opportunities and Challenges Table 4. NAD+ Intravenous Therapy Industry Restraints Table 5. Global NAD+ Intravenous Therapy Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NAD+ Intravenous Therapy Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NAD+ Intravenous Therapy Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global NAD+ Intravenous Therapy Sales Market Share by Manufacturers Table 9. Global NAD+ Intravenous Therapy Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global NAD+ Intravenous Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NAD+ Intravenous Therapy Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NAD+ Intravenous Therapy Manufacturers, Product Type & Application Table 13. Global NAD+ Intravenous Therapy Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NAD+ Intravenous Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of NAD+ Mixed Vitamin Injections Table 17. Major Manufacturers of Pure NAD+ Injection Table 18. Global NAD+ Intravenous Therapy Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global NAD+ Intravenous Therapy Sales by Type (2021-2026) & (K Units) Table 20. Global NAD+ Intravenous Therapy Sales by Type (2027-2032) & (K Units) Table 21. Global NAD+ Intravenous Therapy Sales Market Share by Type (2021-2026) Table 22. Global NAD+ Intravenous Therapy Sales Market Share by Type (2027-2032) Table 23. Global NAD+ Intravenous Therapy Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global NAD+ Intravenous Therapy Revenue by Type (2021-2026) & (K Units) Table 25. Global NAD+ Intravenous Therapy Revenue by Type (2027-2032) & (K Units) Table 26. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021-2026) Table 27. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Residential Table 31. Global NAD+ Intravenous Therapy Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global NAD+ Intravenous Therapy Sales by Application (2021-2026) & (K Units) Table 33. Global NAD+ Intravenous Therapy Sales by Application (2027-2032) & (K Units) Table 34. Global NAD+ Intravenous Therapy Sales Market Share by Application (2021-2026) Table 35. Global NAD+ Intravenous Therapy Sales Market Share by Application (2027-2032) Table 36. Global NAD+ Intravenous Therapy Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global NAD+ Intravenous Therapy Revenue by Application (2021-2026) & (K Units) Table 38. Global NAD+ Intravenous Therapy Revenue by Application (2027-2032) & (K Units) Table 39. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021-2026) Table 40. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2027-2032) Table 41. Global NAD+ Intravenous Therapy Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global NAD+ Intravenous Therapy Sales by Region (2021-2026) & (K Units) Table 43. Global NAD+ Intravenous Therapy Sales Market Share by Region (2021-2026) Table 44. Global NAD+ Intravenous Therapy Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global NAD+ Intravenous Therapy Sales Forecasted Market Share by Region (2027-2032) Table 46. North America NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America NAD+ Intravenous Therapy Sales by Country (2021-2026) & (K Units) Table 48. North America NAD+ Intravenous Therapy Sales by Country (2027-2032) & (K Units) Table 49. Europe NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe NAD+ Intravenous Therapy Sales by Country (2021-2026) & (K Units) Table 51. Europe NAD+ Intravenous Therapy Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific NAD+ Intravenous Therapy Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific NAD+ Intravenous Therapy Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa NAD+ Intravenous Therapy Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa NAD+ Intravenous Therapy Sales by Country (2027-2032) & (K Units) Table 58. Global NAD+ Intravenous Therapy Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global NAD+ Intravenous Therapy Revenue by Region (2021-2026) & (US$ Million) Table 60. Global NAD+ Intravenous Therapy Revenue by Region (2027-2032) & (US$ Million) Table 61. Global NAD+ Intravenous Therapy Revenue Market Share by Region (2021-2026) Table 62. Global NAD+ Intravenous Therapy Revenue Market Share by Region (2027-2032) Table 63. Azivmedics Company Information Table 64. Azivmedics Business Overview Table 65. Azivmedics NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Azivmedics NAD+ Intravenous Therapy Product Portfolio Table 67. Azivmedics Recent Development Table 68. BioReset Medical Company Information Table 69. BioReset Medical Business Overview Table 70. BioReset Medical NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. BioReset Medical NAD+ Intravenous Therapy Product Portfolio Table 72. BioReset Medical Recent Development Table 73. Conciergemdla Company Information Table 74. Conciergemdla Business Overview Table 75. Conciergemdla NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Conciergemdla NAD+ Intravenous Therapy Product Portfolio Table 77. Conciergemdla Recent Development Table 78. Effect Doctors Company Information Table 79. Effect Doctors Business Overview Table 80. Effect Doctors NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Effect Doctors NAD+ Intravenous Therapy Product Portfolio Table 82. Effect Doctors Recent Development Table 83. Hydrate IV Bar Company Information Table 84. Hydrate IV Bar Business Overview Table 85. Hydrate IV Bar NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hydrate IV Bar NAD+ Intravenous Therapy Product Portfolio Table 87. Hydrate IV Bar Recent Development Table 88. IV Boost UK Company Information Table 89. IV Boost UK Business Overview Table 90. IV Boost UK NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. IV Boost UK NAD+ Intravenous Therapy Product Portfolio Table 92. IV Boost UK Recent Development Table 93. LIVV Natural Company Information Table 94. LIVV Natural Business Overview Table 95. LIVV Natural NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LIVV Natural NAD+ Intravenous Therapy Product Portfolio Table 97. LIVV Natural Recent Development Table 98. Mobileivmedics Company Information Table 99. Mobileivmedics Business Overview Table 100. Mobileivmedics NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mobileivmedics NAD+ Intravenous Therapy Product Portfolio Table 102. Mobileivmedics Recent Development Table 103. Nadclinic Company Information Table 104. Nadclinic Business Overview Table 105. Nadclinic NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Nadclinic NAD+ Intravenous Therapy Product Portfolio Table 107. Nadclinic Recent Development Table 108. Premiumhealth Company Information Table 109. Premiumhealth Business Overview Table 110. Premiumhealth NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Premiumhealth NAD+ Intravenous Therapy Product Portfolio Table 112. Premiumhealth Recent Development Table 113. Reset IV Company Information Table 114. Reset IV Business Overview Table 115. Reset IV NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Reset IV NAD+ Intravenous Therapy Product Portfolio Table 117. Reset IV Recent Development Table 118. Rocky Mountain Ivmedics Company Information Table 119. Rocky Mountain Ivmedics Business Overview Table 120. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product Portfolio Table 122. Rocky Mountain Ivmedics Recent Development Table 123. Seaside Skin Care Company Information Table 124. Seaside Skin Care Business Overview Table 125. Seaside Skin Care NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Seaside Skin Care NAD+ Intravenous Therapy Product Portfolio Table 127. Seaside Skin Care Recent Development Table 128. The Wellness Lab Company Information Table 129. The Wellness Lab Business Overview Table 130. The Wellness Lab NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. The Wellness Lab NAD+ Intravenous Therapy Product Portfolio Table 132. The Wellness Lab Recent Development Table 133. Thedripclub Company Information Table 134. Thedripclub Business Overview Table 135. Thedripclub NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Thedripclub NAD+ Intravenous Therapy Product Portfolio Table 137. Thedripclub Recent Development Table 138. Toronto Functional Medicine Centre Company Information Table 139. Toronto Functional Medicine Centre Business Overview Table 140. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product Portfolio Table 142. Toronto Functional Medicine Centre Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. NAD+ Intravenous Therapy Distributors List Table 146. NAD+ Intravenous Therapy Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. NAD+ Intravenous Therapy Product Image Figure 2. Global NAD+ Intravenous Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NAD+ Intravenous Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global NAD+ Intravenous Therapy Sales (2021-2032) & (K Units) Figure 5. Global NAD+ Intravenous Therapy Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 NAD+ Intravenous Therapy Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. NAD+ Mixed Vitamin Injections Image Figure 9. Pure NAD+ Injection Image Figure 10. Global NAD+ Intravenous Therapy Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global NAD+ Intravenous Therapy Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global NAD+ Intravenous Therapy Sales Market Share by Type (2021-2032) Figure 13. Global NAD+ Intravenous Therapy Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global NAD+ Intravenous Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Residential Image Figure 19. Global NAD+ Intravenous Therapy Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global NAD+ Intravenous Therapy Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global NAD+ Intravenous Therapy Sales Market Share by Application (2021-2032) Figure 22. Global NAD+ Intravenous Therapy Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global NAD+ Intravenous Therapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021-2032) Figure 25. North America NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America NAD+ Intravenous Therapy Sales Market Share by Country (2021-2032) Figure 27. U.S. NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe NAD+ Intravenous Therapy Sales Market Share by Country (2021-2032) Figure 32. Germany NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific NAD+ Intravenous Therapy Sales Market Share by Country (2021-2032) Figure 39. China NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa NAD+ Intravenous Therapy Sales Market Share by Country (2021-2032) Figure 47. Brazil NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile NAD+ Intravenous Therapy Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global NAD+ Intravenous Therapy Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global NAD+ Intravenous Therapy Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America NAD+ Intravenous Therapy Revenue (2021-2032) & (US$ Million) Figure 58. North America NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe NAD+ Intravenous Therapy Revenue (2021-2032) & (US$ Million) Figure 60. Europe NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific NAD+ Intravenous Therapy Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa NAD+ Intravenous Therapy Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. NAD+ Intravenous Therapy Value Chain Figure 66. Manufacturing Cost Structure Figure 67. NAD+ Intravenous Therapy Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • NAD+ Mixed Vitamin Injections
  • Pure NAD+ Injection
Applications
  • Clinic
  • Hospital
  • Residential
Companies covered
  • Azivmedics
  • BioReset Medical
  • Conciergemdla
  • Effect Doctors
  • Hydrate IV Bar
  • IV Boost UK
  • LIVV Natural
  • Mobileivmedics
  • Nadclinic
  • Premiumhealth
  • Reset IV
  • Rocky Mountain Ivmedics
  • Seaside Skin Care
  • The Wellness Lab
  • Thedripclub
  • Toronto Functional Medicine Centre

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NAD+ Intravenous Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NAD+ Intravenous Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NAD+ Intravenous Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NAD+ Intravenous Therapy Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NAD+ Intravenous Therapy Market Dynamics
  1. 2.1 NAD+ Intravenous Therapy Industry Trends
  2. 2.2 NAD+ Intravenous Therapy Industry Drivers
  3. 2.3 NAD+ Intravenous Therapy Industry Opportunities and Challenges
  4. 2.4 NAD+ Intravenous Therapy Industry Restraints
3 NAD+ Intravenous Therapy Market by Manufacturers
  1. 3.1 Global NAD+ Intravenous Therapy Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NAD+ Intravenous Therapy Sales by Manufacturers (2021-2026)
  3. 3.3 Global NAD+ Intravenous Therapy Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NAD+ Intravenous Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NAD+ Intravenous Therapy Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NAD+ Intravenous Therapy Manufacturers, Product Type & Application
  7. 3.7 Global NAD+ Intravenous Therapy Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NAD+ Intravenous Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NAD+ Intravenous Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NAD+ Intravenous Therapy Tier 1, Tier 2, and Tier 3
4 NAD+ Intravenous Therapy Market by Type
  1. 4.1 NAD+ Intravenous Therapy Type Introduction
  2. 4.1.1 NAD+ Mixed Vitamin Injections
  3. 4.1.2 Pure NAD+ Injection
  4. 4.2 Global NAD+ Intravenous Therapy Sales by Type
  5. 4.2.1 Global NAD+ Intravenous Therapy Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NAD+ Intravenous Therapy Sales by Type (2021-2032)
  7. 4.2.3 Global NAD+ Intravenous Therapy Sales Market Share by Type (2021-2032)
  8. 4.3 Global NAD+ Intravenous Therapy Revenue by Type
  9. 4.3.1 Global NAD+ Intravenous Therapy Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NAD+ Intravenous Therapy Revenue by Type (2021-2032)
  11. 4.3.3 Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021-2032)
5 NAD+ Intravenous Therapy Market by Application
  1. 5.1 NAD+ Intravenous Therapy Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Residential
  5. 5.2 Global NAD+ Intravenous Therapy Sales by Application
  6. 5.2.1 Global NAD+ Intravenous Therapy Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NAD+ Intravenous Therapy Sales by Application (2021-2032)
  8. 5.2.3 Global NAD+ Intravenous Therapy Sales Market Share by Application (2021-2032)
  9. 5.3 Global NAD+ Intravenous Therapy Revenue by Application
  10. 5.3.1 Global NAD+ Intravenous Therapy Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NAD+ Intravenous Therapy Revenue by Application (2021-2032)
  12. 5.3.3 Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021-2032)
6 Global NAD+ Intravenous Therapy Sales by Region
  1. 6.1 Global NAD+ Intravenous Therapy Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NAD+ Intravenous Therapy Sales by Region (2021-2032)
  3. 6.2.1 Global NAD+ Intravenous Therapy Sales by Region (2021-2026)
  4. 6.2.2 Global NAD+ Intravenous Therapy Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NAD+ Intravenous Therapy Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NAD+ Intravenous Therapy Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NAD+ Intravenous Therapy Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NAD+ Intravenous Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NAD+ Intravenous Therapy Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NAD+ Intravenous Therapy Revenue by Region
  1. 7.1 Global NAD+ Intravenous Therapy Revenue by Region
  2. 7.1.1 Global NAD+ Intravenous Therapy Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NAD+ Intravenous Therapy Revenue by Region (2021-2026)
  4. 7.1.3 Global NAD+ Intravenous Therapy Revenue by Region (2027-2032)
  5. 7.1.4 Global NAD+ Intravenous Therapy Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NAD+ Intravenous Therapy Revenue (2021-2032)
  8. 7.2.2 North America NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NAD+ Intravenous Therapy Revenue (2021-2032)
  11. 7.3.2 Europe NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NAD+ Intravenous Therapy Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NAD+ Intravenous Therapy Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NAD+ Intravenous Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Azivmedics
  2. 8.1.1 Azivmedics Company Information
  3. 8.1.2 Azivmedics Business Overview
  4. 8.1.3 Azivmedics NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Azivmedics NAD+ Intravenous Therapy Product Portfolio
  6. 8.1.5 Azivmedics Recent Developments
  7. 8.2 BioReset Medical
  8. 8.2.1 BioReset Medical Company Information
  9. 8.2.2 BioReset Medical Business Overview
  10. 8.2.3 BioReset Medical NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BioReset Medical NAD+ Intravenous Therapy Product Portfolio
  12. 8.2.5 BioReset Medical Recent Developments
  13. 8.3 Conciergemdla
  14. 8.3.1 Conciergemdla Company Information
  15. 8.3.2 Conciergemdla Business Overview
  16. 8.3.3 Conciergemdla NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Conciergemdla NAD+ Intravenous Therapy Product Portfolio
  18. 8.3.5 Conciergemdla Recent Developments
  19. 8.4 Effect Doctors
  20. 8.4.1 Effect Doctors Company Information
  21. 8.4.2 Effect Doctors Business Overview
  22. 8.4.3 Effect Doctors NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Effect Doctors NAD+ Intravenous Therapy Product Portfolio
  24. 8.4.5 Effect Doctors Recent Developments
  25. 8.5 Hydrate IV Bar
  26. 8.5.1 Hydrate IV Bar Company Information
  27. 8.5.2 Hydrate IV Bar Business Overview
  28. 8.5.3 Hydrate IV Bar NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hydrate IV Bar NAD+ Intravenous Therapy Product Portfolio
  30. 8.5.5 Hydrate IV Bar Recent Developments
  31. 8.6 IV Boost UK
  32. 8.6.1 IV Boost UK Company Information
  33. 8.6.2 IV Boost UK Business Overview
  34. 8.6.3 IV Boost UK NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IV Boost UK NAD+ Intravenous Therapy Product Portfolio
  36. 8.6.5 IV Boost UK Recent Developments
  37. 8.7 LIVV Natural
  38. 8.7.1 LIVV Natural Company Information
  39. 8.7.2 LIVV Natural Business Overview
  40. 8.7.3 LIVV Natural NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LIVV Natural NAD+ Intravenous Therapy Product Portfolio
  42. 8.7.5 LIVV Natural Recent Developments
  43. 8.8 Mobileivmedics
  44. 8.8.1 Mobileivmedics Company Information
  45. 8.8.2 Mobileivmedics Business Overview
  46. 8.8.3 Mobileivmedics NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mobileivmedics NAD+ Intravenous Therapy Product Portfolio
  48. 8.8.5 Mobileivmedics Recent Developments
  49. 8.9 Nadclinic
  50. 8.9.1 Nadclinic Company Information
  51. 8.9.2 Nadclinic Business Overview
  52. 8.9.3 Nadclinic NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nadclinic NAD+ Intravenous Therapy Product Portfolio
  54. 8.9.5 Nadclinic Recent Developments
  55. 8.10 Premiumhealth
  56. 8.10.1 Premiumhealth Company Information
  57. 8.10.2 Premiumhealth Business Overview
  58. 8.10.3 Premiumhealth NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Premiumhealth NAD+ Intravenous Therapy Product Portfolio
  60. 8.10.5 Premiumhealth Recent Developments
  61. 8.11 Reset IV
  62. 8.11.1 Reset IV Company Information
  63. 8.11.2 Reset IV Business Overview
  64. 8.11.3 Reset IV NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Reset IV NAD+ Intravenous Therapy Product Portfolio
  66. 8.11.5 Reset IV Recent Developments
  67. 8.12 Rocky Mountain Ivmedics
  68. 8.12.1 Rocky Mountain Ivmedics Company Information
  69. 8.12.2 Rocky Mountain Ivmedics Business Overview
  70. 8.12.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product Portfolio
  72. 8.12.5 Rocky Mountain Ivmedics Recent Developments
  73. 8.13 Seaside Skin Care
  74. 8.13.1 Seaside Skin Care Company Information
  75. 8.13.2 Seaside Skin Care Business Overview
  76. 8.13.3 Seaside Skin Care NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Seaside Skin Care NAD+ Intravenous Therapy Product Portfolio
  78. 8.13.5 Seaside Skin Care Recent Developments
  79. 8.14 The Wellness Lab
  80. 8.14.1 The Wellness Lab Company Information
  81. 8.14.2 The Wellness Lab Business Overview
  82. 8.14.3 The Wellness Lab NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 The Wellness Lab NAD+ Intravenous Therapy Product Portfolio
  84. 8.14.5 The Wellness Lab Recent Developments
  85. 8.15 Thedripclub
  86. 8.15.1 Thedripclub Company Information
  87. 8.15.2 Thedripclub Business Overview
  88. 8.15.3 Thedripclub NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thedripclub NAD+ Intravenous Therapy Product Portfolio
  90. 8.15.5 Thedripclub Recent Developments
  91. 8.16 Toronto Functional Medicine Centre
  92. 8.16.1 Toronto Functional Medicine Centre Company Information
  93. 8.16.2 Toronto Functional Medicine Centre Business Overview
  94. 8.16.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product Portfolio
  96. 8.16.5 Toronto Functional Medicine Centre Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NAD+ Intravenous Therapy Value Chain Analysis
  2. 9.1.1 NAD+ Intravenous Therapy Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NAD+ Intravenous Therapy Production Mode & Process
  6. 9.2 NAD+ Intravenous Therapy Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NAD+ Intravenous Therapy Distributors
  9. 9.2.3 NAD+ Intravenous Therapy Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst